These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30257201)

  • 1. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
    Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
    Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
    Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
    Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1.
    Lou J; Zhou Q; Lyu X; Cen X; Liu C; Yan Z; Li Y; Tang H; Liu Q; Ding J; Lu Y; Huang H; Xie H; Zhao Y
    J Med Chem; 2024 Jul; 67(13):10795-10830. PubMed ID: 38913996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
    Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
    Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
    Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z
    Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering.
    Harvey EP; Hauseman ZJ; Cohen DT; Rettenmaier TJ; Lee S; Huhn AJ; Wales TE; Seo HS; Luccarelli J; Newman CE; Guerra RM; Bird GH; Dhe-Paganon S; Engen JR; Wells JA; Walensky LD
    Cell Chem Biol; 2020 Jun; 27(6):647-656.e6. PubMed ID: 32413285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
    Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
    ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
    Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
    J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
    Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
    J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.
    Li X; Dou J; You Q; Jiang Z
    Eur J Med Chem; 2021 Aug; 220():113539. PubMed ID: 34034128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A redox switch regulates the structure and function of anti-apoptotic BFL-1.
    Korshavn KJ; Wales TE; Bird GH; Engen JR; Walensky LD
    Nat Struct Mol Biol; 2020 Sep; 27(9):781-789. PubMed ID: 32661419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
    Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
    Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.
    Feng X; Yan Z; Zhou F; Lou J; Lyu X; Ren X; Zeng Z; Liu C; Zhang S; Zhu D; Huang H; Yang J; Zhao Y
    Eur J Med Chem; 2022 Jun; 236():114327. PubMed ID: 35385805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.
    Tarte K; Jourdan M; Veyrune JL; Berberich I; Fiol G; Redal N; Shaughnessy J; Klein B
    Br J Haematol; 2004 May; 125(3):373-82. PubMed ID: 15086420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
    Brien G; Trescol-Biemont MC; Bonnefoy-Bérard N
    Oncogene; 2007 Aug; 26(39):5828-32. PubMed ID: 17353899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein.
    Brien G; Debaud AL; Bickle M; Trescol-Biemont MC; Moncorge O; Colas P; Bonnefoy-Berard N
    Biochemistry; 2011 Jun; 50(23):5120-9. PubMed ID: 21563784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling.
    Vier J; Groth M; Sochalska M; Kirschnek S
    Cell Death Dis; 2016 Feb; 7(2):e2103. PubMed ID: 26890142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
    Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
    Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
    Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
    Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.